Japan Cell Culture Media Market Size & Outlook, 2026-2033
Related Markets
Japan cell culture media market highlights
- The Japan cell culture media market generated a revenue of USD 184.1 million in 2024 and is expected to reach USD 513.0 million by 2033.
- The Japan market is expected to grow at a CAGR of 12.4% from 2025 to 2033.
- In terms of segment, serum-free media was the largest revenue generating product in 2024.
- Serum-free Media is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture media market data book summary
| Market revenue in 2024 | USD 184.1 million |
| Market revenue in 2033 | USD 513.0 million |
| Growth rate | 12.4% (CAGR from 2025 to 2033) |
| Largest segment | Serum-free media |
| Fastest growing segment | Serum-free Media |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum-free Media, Chemically Defined Media, Specialty Media, Stem Cell Culture Media, Other Cell Culture Media, Classical Media, Immunology Media |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH, Cell Biologics, Inc. |
Other key industry trends
- In terms of revenue, Japan accounted for 4.3% of the global cell culture media market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China cell culture media market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,007.1 million by 2033.
Serum-free media was the largest segment with a revenue share of 36.07% in 2025. Horizon Databook has segmented the Japan cell culture media market based on serum-free media, chemically defined media, specialty media, stem cell culture media, other cell culture media, classical media, immunology media covering the revenue growth of each sub-segment from 2021 to 2033.
There are two acts for regulation of regenerative medicines and cell therapy in Japan—The Act on the Safety of Regenerative Medicine (ASRM) and the Act on Pharmaceutical and Medical Devices (PMD Act). These two laws were enacted in November 2014. These laws fast track the process to the market for stem-cell-based treatments and other types of regenerative medicine.
The Act on the Safety of Regenerative Medicine allows operating players to register a therapy under one of three risk categories. Furthermore, it allows clinics and hospitals to commercialize cellular therapies without going through the usual kinds of trials to prove that a medicine is effective. It is mandatory for a hospital to have a cell processing facility certified by the Ministry of Health, Labor and Welfare to offer cellular therapies.
In addition, the Pharmaceutical and Medical Devices Act permits for conditional approval of therapies that have gone through some clinical testing. Companies are given the chance to promote a treatment across the country and get insurance payments; however, they are also required to gather additional efficacy data over a 7-year period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Media Market Scope
Cell Culture Media Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cell Biologics, Inc. | View profile | 1-10 | Chicago, Illinois, United States, North America | http://www.cellbiologics.net |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Japan cell culture media market size, by application, 2021-2033 (US$M)
Japan Cell Culture Media Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
